oncotherapynetwork.com
Oncotherapy Network
We've noticed that you're using an ad blocker. Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker. How do I disable my ad blocker? How to disable your ad blocker for our site:. Adblock / Adblock Plus. Click on the AdBlock / AdBlock Plus icon on the top right of your browser. Click Don’t run on pages on this domain. OR Enabled on this site. Close this help box and click "It's off now". Dec 21, 2017.
oncotherapyresources.com
SD-IORT > Home
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is SD-IORT available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is SD-IORT available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? You are here: Home.
oncotherapysolutions.com
Home Page
Focusing on scientific discovery and innovation in targeted therapy and immuno-oncology to save human lives:. Cancer is the second most common cause of death in the US, exceeded only by heart disease. One of every four deaths in the United States is due to cancer. The American Cancer Society estimates that in 2014, about 1,665,540 Americans were diagnosed with invasive cancer, and 585,720 Americans died of this disease. The company currently has three preclinical programs:. Preclinical studies of these d...
oncotherex.com
Oncotherex | Cancers du sein et de l'ovaire
Cancers du sein et de l'ovaire. Cancers du sein et de l'ovaire. Oncotherex est spécialisée dans la mise en culture de tumeurs du sein et de l'ovaire permettant de tester l'efficacité thérapeutique de molécules innovantes. En savoir plus sur Oncotherex. Vous êtes une start-up, un laboratoire académique ou une entreprise pharmaceutique et vous souhaitez tester des molécules innovantes, venez vite découvrir nos offres. Oncotherex propose de nombreux tests sur ses tumeurs du sein et de l'ovaire. Bienvenue su...
oncotherics.blogspot.com
OncoTherics News
Latest news and events from Oncotherics. Wednesday, 17 December 2014. OncoTherics signs collaboration agreement with University of Cambridge. OncoTherics has signed a collaboration agreement with the University of Cambridge to progress a series of novel preclinical investigations using OCT1002 in Pancreatic Tumour models. The investigations will augment OncoTherics formal preclinical studies, providing useful additional information about OCT1002 in Pancreatic Cancer. Wednesday, 16 July 2014. Weiss Medall...
oncotherix.com
Oncotherix / InCell-RT™
Oncotherix™ is a clinical stage oncology company developing InCell-RT™. Herapy) for the treatment of locally-advanced cancers. InCell-RT is DNA-ligated nanometer-scale intracellular radiotherapy locally administered via catheter-based infusion systems. Oncotherix is developing InCell-RT as a safer and more effective treatment for numerous locally-advanced cancers, starting with recurrent ovarian cancer and high grade glioma brain cancer. Therapeutic Advantages of InCell-RT. 12635 E. Montview Blvd.
